The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Somatostatin Analogs Market Research Report 2019

Global Somatostatin Analogs Market Research Report 2019

Publishing Date : Feb, 2019

License Type :
 

Report Code : 1424417

No of Pages : 98

Synopsis
Somatostatin analogues stop your body from making too many hormones. They can reduce the symptoms of carcinoid syndrome and may slow down tumour growth.
Somatostatin is a protein made naturally in the body. It is made by: a gland in the brain (hypothalamus), the stomach, the pancreas and the bowel. Somatostatin can slow down hormone production, including many of the gut hormones, slows down the emptying of the stomach and bowel, controls the release of hormones made by the pancreas, including insulin and, slows down or stops the release of growth hormones. Rise in the research and development and launch of novel drug therapies are the factors driving the growth of somatostatin analogs over the forecast period.

The global Somatostatin Analogs market is valued at 2430 million US$ in 2018 is expected to reach 3580 million US$ by the end of 2025, growing at a CAGR of 5.0% during 2019-2025.
This report focuses on Somatostatin Analogs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Somatostatin Analogs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

  • Novartis
  • Peptron
  • Chiasma
  • Ipsen Biopharmaceutical

...
Segment by Regions

  • North America
  • Europe
  • China
  • Japan

Segment by Type

  • Octreotide
  • Lanreotide
  • Pasireotide

Segment by Application

  • Acromegaly
  • Carcinoid Syndrome
  • Neuroendocrine Tumor
  • Cushing Syndrome
  • Others

Study objectives
• To analyze and research the global capacity, production, revenue, consumption, status and forecast.
• To present the key manufacturers, capacity, production, revenue, market share, and recent development.
• To focus on the global key manufacturers, to define, describe and analyze the market competition landscape,
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

Topics covered in this report are:
1. Market Overview (Segment by Type, Application, Region, Market Size, Revenue & Production)
2. Market Competition by Manufacturers (Production & Revenue Market Share, Average Price, Competitive Situation and Trends, Mergers & Acquisitions, Expansion)
3. Production & Revenue Market Share by Regions: Global, North America, Europe, China, and Japan
4. Consumption Analysis by Regions (2014-2019)
5. Production, Revenue, Price Trend, and Growth Rate by Type
6. Market Analysis by Applications: Market Share and Growth Rate (2014-2019)
7. Key Companies Profile (Product Introduction, Application, Specification, Production, Revenue, Price and Gross Margin)
8. Manufacturing Cost Analysis (Raw Material, Price, Key Suppliers, and Industrial Chain Analysis)
9. Marketing Channel, Distributors and Customers (Direct / Indirect Marketing, Distributors List, Customers)
10. Market Dynamics (Trends, Opportunities, Drivers, Challenges, and Influence Factors)
11. Market Forecast to 2025 for Production, Revenue, Growth Rate, Trends, and Forecast by Types and Applications (2019-2025)
12. Research Findings and Conclusion (Key Takeaway of the research report)
13. Methodology and Data Source

Index

Table of Contents

Executive Summary
1 Somatostatin Analogs Market Overview
1.1 Product Overview and Scope of Somatostatin Analogs
1.2 Somatostatin Analogs Segment by Type
1.2.1 Global Somatostatin Analogs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Octreotide
1.2.3 Lanreotide
1.2.4 Pasireotide
1.3 Somatostatin Analogs Segment by Application
1.3.1 Somatostatin Analogs Consumption Comparison by Application (2014-2025)
1.3.2 Acromegaly
1.3.3 Carcinoid Syndrome
1.3.4 Neuroendocrine Tumor
1.3.5 Cushing Syndrome
1.3.6 Others
1.4 Global Somatostatin Analogs Market by Region
1.4.1 Global Somatostatin Analogs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Somatostatin Analogs Market Size
1.5.1 Global Somatostatin Analogs Revenue (2014-2025)
1.5.2 Global Somatostatin Analogs Production (2014-2025)

2 Global Somatostatin Analogs Market Competition by Manufacturers
2.1 Global Somatostatin Analogs Production Market Share by Manufacturers (2014-2019)
2.2 Global Somatostatin Analogs Revenue Share by Manufacturers (2014-2019)
2.3 Global Somatostatin Analogs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Somatostatin Analogs Production Sites, Area Served, Product Types
2.5 Somatostatin Analogs Market Competitive Situation and Trends
2.5.1 Somatostatin Analogs Market Concentration Rate
2.5.2 Somatostatin Analogs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Somatostatin Analogs Production Market Share by Regions
3.1 Global Somatostatin Analogs Production Market Share by Regions
3.2 Global Somatostatin Analogs Revenue Market Share by Regions (2014-2019)
3.3 Global Somatostatin Analogs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Somatostatin Analogs Production
3.4.1 North America Somatostatin Analogs Production Growth Rate (2014-2019)
3.4.2 North America Somatostatin Analogs Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Somatostatin Analogs Production
3.5.1 Europe Somatostatin Analogs Production Growth Rate (2014-2019)
3.5.2 Europe Somatostatin Analogs Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Somatostatin Analogs Production (2014-2019)
3.6.1 China Somatostatin Analogs Production Growth Rate (2014-2019)
3.6.2 China Somatostatin Analogs Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Somatostatin Analogs Production (2014-2019)
3.7.1 Japan Somatostatin Analogs Production Growth Rate (2014-2019)
3.7.2 Japan Somatostatin Analogs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Somatostatin Analogs Consumption by Regions
4.1 Global Somatostatin Analogs Consumption by Regions
4.2 North America Somatostatin Analogs Consumption (2014-2019)
4.3 Europe Somatostatin Analogs Consumption (2014-2019)
4.4 China Somatostatin Analogs Consumption (2014-2019)
4.5 Japan Somatostatin Analogs Consumption (2014-2019)

5 Global Somatostatin Analogs Production, Revenue, Price Trend by Type
5.1 Global Somatostatin Analogs Production Market Share by Type (2014-2019)
5.2 Global Somatostatin Analogs Revenue Market Share by Type (2014-2019)
5.3 Global Somatostatin Analogs Price by Type (2014-2019)
5.4 Global Somatostatin Analogs Production Growth by Type (2014-2019)

6 Global Somatostatin Analogs Market Analysis by Applications
6.1 Global Somatostatin Analogs Consumption Market Share by Application (2014-2019)
6.2 Global Somatostatin Analogs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Somatostatin Analogs Business
7.1 Novartis
7.1.1 Novartis Somatostatin Analogs Production Sites and Area Served
7.1.2 Somatostatin Analogs Product Introduction, Application and Specification
7.1.3 Novartis Somatostatin Analogs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Peptron
7.2.1 Peptron Somatostatin Analogs Production Sites and Area Served
7.2.2 Somatostatin Analogs Product Introduction, Application and Specification
7.2.3 Peptron Somatostatin Analogs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Chiasma
7.3.1 Chiasma Somatostatin Analogs Production Sites and Area Served
7.3.2 Somatostatin Analogs Product Introduction, Application and Specification
7.3.3 Chiasma Somatostatin Analogs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Ipsen Biopharmaceutical
7.4.1 Ipsen Biopharmaceutical Somatostatin Analogs Production Sites and Area Served
7.4.2 Somatostatin Analogs Product Introduction, Application and Specification
7.4.3 Ipsen Biopharmaceutical Somatostatin Analogs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served

8 Somatostatin Analogs Manufacturing Cost Analysis
8.1 Somatostatin Analogs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Somatostatin Analogs
8.4 Somatostatin Analogs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Somatostatin Analogs Distributors List
9.3 Somatostatin Analogs Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Somatostatin Analogs Market Forecast
11.1 Global Somatostatin Analogs Production, Revenue Forecast
11.1.1 Global Somatostatin Analogs Production Growth Rate Forecast (2019-2025)
11.1.2 Global Somatostatin Analogs Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Somatostatin Analogs Price and Trend Forecast (2019-2025)
11.2 Global Somatostatin Analogs Production Forecast by Regions (2019-2025)
11.2.1 North America Somatostatin Analogs Production, Revenue Forecast (2019-2025)
11.2.2 Europe Somatostatin Analogs Production, Revenue Forecast (2019-2025)
11.2.3 China Somatostatin Analogs Production, Revenue Forecast (2019-2025)
11.2.4 Japan Somatostatin Analogs Production, Revenue Forecast (2019-2025)
11.3 Global Somatostatin Analogs Consumption Forecast by Regions (2019-2025)
11.3.1 North America Somatostatin Analogs Consumption Forecast (2019-2025)
11.3.2 Europe Somatostatin Analogs Consumption Forecast (2019-2025)
11.3.3 China Somatostatin Analogs Consumption Forecast (2019-2025)
11.3.4 Japan Somatostatin Analogs Consumption Forecast (2019-2025)
11.4 Global Somatostatin Analogs Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Somatostatin Analogs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables

List of Tables and Figures

Figure Picture of Somatostatin Analogs
Table Global Somatostatin Analogs Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Somatostatin Analogs Production Market Share by Types in 2018
Figure Octreotide Product Picture
Table Octreotide Major Manufacturers
Figure Lanreotide Product Picture
Table Lanreotide Major Manufacturers
Figure Pasireotide Product Picture
Table Pasireotide Major Manufacturers
Table Global Somatostatin Analogs Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Somatostatin Analogs Consumption Market Share by Applications in 2018
Figure Acromegaly
Figure Carcinoid Syndrome
Figure Neuroendocrine Tumor
Figure Cushing Syndrome
Figure Others
Table Somatostatin Analogs Market Size (Million US$) Comparison by Regions (2014-2025)
Figure North America Somatostatin Analogs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Somatostatin Analogs Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Somatostatin Analogs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Somatostatin Analogs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Somatostatin Analogs Revenue (Million USD) (2014-2025)
Figure Global Somatostatin Analogs Production (K MT) (2014-2025)
Table Global Somatostatin Analogs Production (K MT) of Key Manufacturers (2014-2019)
Table Global Somatostatin Analogs Production Share by Manufacturers (2014-2019)
Figure Somatostatin Analogs Production Share by Manufacturers in 2018
Table Global Somatostatin Analogs Revenue (Million USD) by Manufacturers (2014-2019)
Table Global Somatostatin Analogs Revenue Share by Manufacturers (2014-2019)
Figure Global Somatostatin Analogs Revenue Share by Manufacturers in 2018
Table Global Market Somatostatin Analogs Average Price (USD/MT) of Key Manufacturers (2014-2019)
Figure Global Market Somatostatin Analogs Average Price (USD/MT) of Key Manufacturers in 2018
Table Manufacturers Somatostatin Analogs Production Sites and Area Served
Table Manufacturers Somatostatin Analogs Product Types
Figure Somatostatin Analogs Market Share of Top 5 Manufacturers
Figure Somatostatin Analogs Market Share of Top 10 Manufacturers
Table Global Somatostatin Analogs Production (K MT) by Region (2014-2019)
Table Global Somatostatin Analogs Production Market Share by Region (2014-2019)
Figure Global Somatostatin Analogs Production Market Share by Region (2014-2019)
Figure Global Somatostatin Analogs Production Market Share by Region in 2018
Table Global Somatostatin Analogs Revenue (Million USD) by Region (2014-2019)
Table Global Somatostatin Analogs Revenue Market Share by Region (2014-2019)
Figure Global Somatostatin Analogs Revenue Market Share by Region (2014-2019)
Figure Global Somatostatin Analogs Revenue Market Share by Region in 2018
Figure Global Somatostatin Analogs Production (K MT) Growth Rate (2014-2019)
Table Global Somatostatin Analogs Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Figure North America Somatostatin Analogs Production (K MT) Growth Rate (2014-2019)
Table North America Somatostatin Analogs Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Europe Somatostatin Analogs Production (K MT) Growth Rate (2014-2019)
Table Europe Somatostatin Analogs Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure China Somatostatin Analogs Production (K MT) Growth Rate (2014-2019)
Table China Somatostatin Analogs Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Japan Somatostatin Analogs Production (K MT) Growth Rate (2014-2019)
Table Japan Somatostatin Analogs Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Global Somatostatin Analogs Consumption (K MT) Market by Region (2014-2019)
Table Global Somatostatin Analogs Consumption Market Share by Region (2014-2019)
Figure Global Somatostatin Analogs Consumption Market Share by Region (2014-2019)
Figure Global Somatostatin Analogs Consumption Market Share by Region in 2018
Figure North America Somatostatin Analogs Consumption Growth Rate (2014-2019) (K MT)
Figure Europe Somatostatin Analogs Consumption Growth Rate (2014-2019) (K MT)
Figure China Somatostatin Analogs Consumption Growth Rate (2014-2019) (K MT)
Figure Japan Somatostatin Analogs Consumption Growth Rate (2014-2019) (K MT)
Table Global Somatostatin Analogs Production (K MT) by Type (2014-2019)
Table Global Somatostatin Analogs Production Share by Type (2014-2019)
Figure Production Market Share of Somatostatin Analogs by Type (2014-2019)
Figure Production Market Share of Somatostatin Analogs by Type in 2018
Table Global Somatostatin Analogs Revenue (Million USD) by Type (2014-2019)
Table Global Somatostatin Analogs Revenue Share by Type (2014-2019)
Figure Revenue Share of Somatostatin Analogs by Type (2014-2019)
Figure Revenue Market Share of Somatostatin Analogs by Type in 2018
Table Global Somatostatin Analogs Price (USD/MT) by Type (2014-2019)
Figure Global Somatostatin Analogs Production Growth by Type (2014-2019) (K MT)
Table Global Somatostatin Analogs Consumption (K MT) by Application (2014-2019)
Table Global Somatostatin Analogs Consumption Market Share by Application (2014-2019)
Figure Global Somatostatin Analogs Consumption Market Share by Applications (2014-2019)
Figure Global Somatostatin Analogs Consumption Market Share by Application in 2018
Table Global Somatostatin Analogs Consumption Growth Rate by Application (2014-2019)
Figure Global Somatostatin Analogs Consumption Growth Rate by Application (2014-2019)
Table Novartis Somatostatin Analogs Production Sites and Area Served
Table Novartis Product Introduction, Application and Specification
Table Novartis Somatostatin Analogs Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Novartis Somatostatin Analogs Production Growth Rate (2014-2019)
Figure Novartis Somatostatin Analogs Production Market Share (2014-2019)
Figure Novartis Somatostatin Analogs Revenue Market Share (2014-2019)
Table Novartis Main Business and Markets Served
Table Peptron Somatostatin Analogs Production Sites and Area Served
Table Peptron Product Introduction, Application and Specification
Table Peptron Somatostatin Analogs Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Peptron Somatostatin Analogs Production Growth Rate (2014-2019)
Figure Peptron Somatostatin Analogs Production Market Share (2014-2019)
Figure Peptron Somatostatin Analogs Revenue Market Share (2014-2019)
Table Peptron Main Business and Markets Served
Table Chiasma Somatostatin Analogs Production Sites and Area Served
Table Chiasma Product Introduction, Application and Specification
Table Chiasma Somatostatin Analogs Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Chiasma Somatostatin Analogs Production Growth Rate (2014-2019)
Figure Chiasma Somatostatin Analogs Production Market Share (2014-2019)
Figure Chiasma Somatostatin Analogs Revenue Market Share (2014-2019)
Table Chiasma Main Business and Markets Served
Table Ipsen Biopharmaceutical Somatostatin Analogs Production Sites and Area Served
Table Ipsen Biopharmaceutical Product Introduction, Application and Specification
Table Ipsen Biopharmaceutical Somatostatin Analogs Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Ipsen Biopharmaceutical Somatostatin Analogs Production Growth Rate (2014-2019)
Figure Ipsen Biopharmaceutical Somatostatin Analogs Production Market Share (2014-2019)
Figure Ipsen Biopharmaceutical Somatostatin Analogs Revenue Market Share (2014-2019)
Table Ipsen Biopharmaceutical Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Somatostatin Analogs
Figure Manufacturing Process Analysis of Somatostatin Analogs
Figure Somatostatin Analogs Industrial Chain Analysis
Table Somatostatin Analogs Distributors List
Table Somatostatin Analogs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Somatostatin Analogs Production (K MT) and Growth Rate Forecast (2019-2025)
Figure Global Somatostatin Analogs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Somatostatin Analogs Price and Trend Forecast (2019-2025)
Table Global Somatostatin Analogs Production (K MT) Forecast by Region (2019-2025)
Figure Global Somatostatin Analogs Production Market Share Forecast by Region (2019-2025)
Figure North America Somatostatin Analogs Production (K MT) and Growth Rate Forecast (2019-2025)
Figure North America Somatostatin Analogs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Somatostatin Analogs Production (K MT) and Growth Rate Forecast (2019-2025)
Figure Europe Somatostatin Analogs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure China Somatostatin Analogs Production (K MT) and Growth Rate Forecast (2019-2025)
Figure China Somatostatin Analogs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Somatostatin Analogs Production (K MT) and Growth Rate Forecast (2019-2025)
Figure Japan Somatostatin Analogs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Somatostatin Analogs Consumption (K MT) Forecast by Regions (2019-2025)
Figure Global Somatostatin Analogs Consumption Market Share Forecast by Regions (2019-2025)
Figure North America Somatostatin Analogs Consumption (K MT) Growth Rate Forecast (2019-2025)
Figure Europe Somatostatin Analogs Consumption (K MT) Growth Rate Forecast (2019-2025)
Figure China Somatostatin Analogs Consumption (K MT) Growth Rate Forecast (2019-2025)
Figure Japan Somatostatin Analogs Consumption (K MT) Growth Rate Forecast (2019-2025)
Table Global Somatostatin Analogs Production (K MT) Forecast by Type (2019-2025)
Figure Global Somatostatin Analogs Production (K MT) Forecast by Type (2019-2025)
Table Global Somatostatin Analogs Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Somatostatin Analogs Revenue Market Share Forecast by Type (2019-2025)
Table Global Somatostatin Analogs Price (USD/MT) Forecast by Type (2019-2025)
Table Global Somatostatin Analogs Consumption (K MT) Forecast by Application (2019-2025)
Figure Global Somatostatin Analogs Consumption Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Published By : QY Research

Why ‘The Market Reports’